Back to Search
STEVEN FISHBANE, M.D.
M.D.
Specialist
NPI: 1730143900IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
182399(NY)
CMS Specialties
PrimaryNEPHROLOGY
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1988
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Interventions for itch in people with advanced chronic kidney disease.
PMID 33283264·Cochrane Database Syst Rev·2020
1-meta
The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial.
PMID 23453391·J Ren Nutr·2013
2-rct
Anemia in chronic kidney disease: status of new therapies.
PMID 19434048·Curr Opin Nephrol Hypertens·2009
6-review
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
PMID 18987297·Clin J Am Soc Nephrol·2009
8-other
Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
PMID 19596163·Am J Kidney Dis·2009
2-rct
Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective.
PMID 18818680·Kidney Int·2009
6-review
Anemia and cardiovascular risk in the patient with kidney disease.
PMID 18760752·Heart Fail Clin·2008
6-review
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
PMID 18945995·Clin J Am Soc Nephrol·2008
4-observational
N-acetylcysteine in the prevention of contrast-induced nephropathy.
PMID 18003766·Clin J Am Soc Nephrol·2008
6-review
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.
PMID 17942772·Clin J Am Soc Nephrol·2007
6-review
Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration.
PMID 17962427·J Clin Pharmacol·2007
2-rct
The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?
PMID 17597700·Kidney Int·2007
6-review
What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
PMID 17170538·Blood Purif·2007
6-review
Refractory anemia in a patient with allergy to intravenous iron drugs.
PMID 16625145·Kidney Int·2006
5-case
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
PMID 16105069·Kidney Int·2005
3-trial
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
PMID 14747371·J Am Soc Nephrol·2004
6-review
Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells.
PMID 14717915·Kidney Int·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 OLD COUNTRY RD, SUITE 135
MINEOLA, NY 11501 - Phone
- (516) 663-2170
Quick Facts
- NPI
- 1730143900
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile